Alpine Immune Sciences Stock Price To Sales
Alpine Immune Sciences fundamentals help investors to digest information that contributes to Alpine Immune's financial success or failures. It also enables traders to predict the movement of Alpine Stock. The fundamental analysis module provides a way to measure Alpine Immune's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alpine Immune stock.
Alpine |
Alpine Immune Sciences Company Price To Sales Analysis
Alpine Immune's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Alpine Immune Price To Sales | 71.68 X |
Most of Alpine Immune's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alpine Immune Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Alpine Immune Sciences has a Price To Sales of 71 times. This is 234.95% higher than that of the Biotechnology sector and 27.16% lower than that of the Health Care industry. The price to sales for all United States stocks is notably lower than that of the firm.
Alpine Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alpine Immune's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alpine Immune could also be used in its relative valuation, which is a method of valuing Alpine Immune by comparing valuation metrics of similar companies.Alpine Immune is currently under evaluation in price to sales category among its peers.
Alpine Fundamentals
| Return On Equity | -0.15 | |||
| Return On Asset | -0.1 | |||
| Profit Margin | (0.65) % | |||
| Operating Margin | (3.23) % | |||
| Current Valuation | 4.16 B | |||
| Shares Outstanding | 68.6 M | |||
| Shares Owned By Insiders | 4.60 % | |||
| Shares Owned By Institutions | 99.46 % | |||
| Number Of Shares Shorted | 3.89 M | |||
| Price To Earning | (32.69) X | |||
| Price To Book | 12.87 X | |||
| Price To Sales | 71.68 X | |||
| Revenue | 58.88 M | |||
| Gross Profit | (40.18 M) | |||
| EBITDA | (43.67 M) | |||
| Net Income | (32.18 M) | |||
| Cash And Equivalents | 167.86 M | |||
| Cash Per Share | 5.52 X | |||
| Total Debt | 9.91 M | |||
| Debt To Equity | 0.17 % | |||
| Current Ratio | 2.75 X | |||
| Book Value Per Share | 5.08 X | |||
| Cash Flow From Operations | (79.01 M) | |||
| Short Ratio | 0.96 X | |||
| Earnings Per Share | (0.64) X | |||
| Target Price | 62.0 | |||
| Number Of Employees | 142 | |||
| Beta | 0.97 | |||
| Market Capitalization | 4.46 B | |||
| Total Asset | 381.81 M | |||
| Retained Earnings | (256.14 M) | |||
| Working Capital | 288.05 M | |||
| Current Asset | 25.53 M | |||
| Current Liabilities | 3.39 M | |||
| Net Asset | 381.81 M |
Pair Trading with Alpine Immune
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alpine Immune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alpine Immune will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Xerox Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xerox Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xerox Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xerox Corp to buy it.
The correlation of Xerox Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xerox Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xerox Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xerox Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Alpine Stock
If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Directory Find actively traded commodities issued by global exchanges |